Merger • Life Science

Valneva Acquires Vivalis SA

On January 28, 2013, Valneva acquired life science company Vivalis SA

Acquisition Context

This is Valneva’s 1st transaction in the Life Science sector.
This is Valneva’s 1st transaction in France.

Explore All 191 Merger Life Science Deals - Search the Database Free

M&A Deal Summary
Date	January 28, 2013
Target	Vivalis SA
Sector	Life Science
Buyer(s)	Valneva
Deal Type	Merger

Target Company

Vivalis SA

Nantes, France

Vivalis is a biopharmaceutical company that provides innovative cell-based solutions to the biotechnology and pharmaceutical industry for the manufacture of vaccines and recombinant proteins, and develops monoclonal antibodies for the prevention and treatment of diseases with unmet medical needs.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Valneva

Saint-Herblain, France

Category	Company
Founded	1998
Sector	Life Science
Employees	700
Revenue	170M EUR (2024)

DESCRIPTION

Valneva is a biotechnology company that focuses on the development of modern prophylactic and therapeutic vaccines against infectious diseases. Valneva was founded in 1998 and is based in Saint-Herblain, France.

Deal Context for Buyer	#
Overall	2 of 2
Sector: Life Science	1 of 1
Type: Merger	1 of 1
Country: France	1 of 1
Year: 2013	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2008-08-05	Iomai Gaithersburg, Pennsylvania, United States Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections.	Buy	€75M

DATE

TARGET

DEAL TYPE

VALUE

2008-08-05

Iomai

Gaithersburg, Pennsylvania, United States

Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections.

Buy

€75M

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2023-07-03	Valneva - Clinical Trial Manufacturing Unit Stockholm, Sweden Valneva's Clinical Trial Manufacturing Unit provides biologics manufacturing services.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2023-07-03

Valneva - Clinical Trial Manufacturing Unit

Stockholm, Sweden

Valneva's Clinical Trial Manufacturing Unit provides biologics manufacturing services.

Sell

Explore Related M&A Activity

Life Science M&A - Merger M&A Deals - France M&A - 2013 M&A